Meridian Bioscience News
Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene® MycoplasmaBusiness Wire Jun 10
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Mycoplasma pneumonia , its fourth assay on the illumigene platform.
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Hutchinson Technology (HTCH), a filing with the SEC revealed that on Thursday, Director [...]
Just the facts, Fool.
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Meridian Bioscience Inc.